1-7 of 7
Giuseppe Saglio
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Identifying the Time to Change BCR-ABL Inhibitor Therapy in Patients with Chronic Myeloid Leukemia

Subject Area:
Hematology , Oncology
Michael R. Savona, Giuseppe Saglio
Journal: Acta Haematologica
Acta Haematol (2013) 130 (4): 268–278.
https://doi.org/10.1159/000353163
Published Online: 15 August 2013
View articletitled, Identifying the Time to Change BCR-ABL Inhibitor Therapy in Patients with Chronic Myeloid Leukemia
Open the PDF for Identifying the Time to Change BCR-ABL Inhibitor Therapy in Patients with Chronic Myeloid Leukemia in another window
Journal Articles

Composition of the γ -Chains of Human Fetal Hemoglobin at Birth and during Intrauterine Life

Subject Area:
Hematology , Oncology
Giuseppe Saglio, Umberto Mazza, Clara Camaschella, Tullio Meloni, Maria Ausilia Ciocca-Vasino, Pier Giorgio Pich, Giuseppe Ricco
Journal: Acta Haematologica
Acta Haematol (1979) 62 (1): 45–50.
https://doi.org/10.1159/000207535
Published Online: 03 March 2009
View articletitled, Composition of the γ -Chains of Human Fetal Hemoglobin at Birth and during Intrauterine Life
Open the PDF for Composition of the γ -Chains of Human Fetal Hemoglobin at Birth and during Intrauterine Life in another window
Journal Articles

Biological Determinants of Long-Term Survival in Chronic Myelogenous Leukemia Patients Treated with Conventional Chemotherapy

Subject Area:
Hematology , Oncology
Paolo Foa, Alessandra Iurlo, Attilio Orazi, Giuseppe Saglio, Sonia Ribera, Francesco Bertoni, Sarah Caldiera, Monica Fornier, Anna Teresa Maiolo
Journal: Acta Haematologica
Acta Haematol (1997) 97 (3): 187–188.
https://doi.org/10.1159/000203679
Published Online: 17 February 2009
View articletitled, Biological Determinants of Long-Term Survival in Chronic Myelogenous Leukemia Patients Treated with Conventional Chemotherapy
Open the PDF for Biological Determinants of Long-Term Survival in Chronic Myelogenous Leukemia Patients Treated with Conventional Chemotherapy in another window
Journal Articles

AIDS-Related Non-Hodgkin’s Lymphomas: Molecular Genetics, Viral Infection and Cytokine Deregulation

Subject Area:
Hematology , Oncology
Gianluca Gaidano, Cristina Pastore, Annunziata Gloghini, Gisella Volpe, Paolo Ghia, Giuseppe Saglio, Antonino Carbone
Journal: Acta Haematologica
Acta Haematol (1996) 95 (3-4): 193–198.
https://doi.org/10.1159/000203877
Published Online: 17 February 2009
View articletitled, AIDS-Related Non-Hodgkin’s Lymphomas: Molecular Genetics, Viral Infection and Cytokine Deregulation
Open the PDF for AIDS-Related Non-Hodgkin’s Lymphomas: Molecular Genetics, Viral Infection and Cytokine Deregulation in another window
Journal Articles

Detection of Humoral Immune Responses against WT1 Antigen in Patients Affected by Different Hematological Malignancies

Subject Area:
Hematology , Oncology
Paolo Nicoli, Ilaria Defilippi, Sonia Carturan, Antonella Roetto, Francesca Messa, Francesca Arruga, Emanuela Messa, Antonia Rotolo, Ilaria Iacobucci, Enrico Bracco, Giuseppe Saglio, Daniela Cilloni
Journal: Acta Haematologica
Acta Haematol (2008) 120 (1): 47–50.
https://doi.org/10.1159/000158576
Published Online: 30 September 2008
View articletitled, Detection of Humoral Immune Responses against WT1 Antigen in Patients Affected by Different Hematological Malignancies
Open the PDF for Detection of Humoral Immune Responses against WT1 Antigen in Patients Affected by Different Hematological Malignancies in another window
Journal Articles

Very Low Doses of Thalidomide as Single Agent in Relapsed/Refractory Multiple Myeloma

Subject Area:
Hematology , Oncology
Tommasina Guglielmelli, Sara Capella, Giuseppe Saglio
Journal: Acta Haematologica
Acta Haematol (2006) 116 (1): 70–71.
https://doi.org/10.1159/000092352
Published Online: 03 July 2006
View articletitled, Very Low Doses of Thalidomide as Single Agent in Relapsed/Refractory Multiple Myeloma
Open the PDF for Very Low Doses of Thalidomide as Single Agent in Relapsed/Refractory Multiple Myeloma in another window
Journal Articles

WT1 as a Universal Marker for Minimal Residual Disease Detection and Quantification in Myeloid Leukemias and in Myelodysplastic Syndrome

Subject Area:
Hematology , Oncology
Daniela Cilloni, Giuseppe Saglio
Journal: Acta Haematologica
Acta Haematol (2004) 112 (1-2): 79–84.
https://doi.org/10.1159/000077562
Published Online: 09 June 2004
View articletitled, WT1 as a Universal Marker for Minimal Residual Disease Detection and Quantification in Myeloid Leukemias and in Myelodysplastic Syndrome
Open the PDF for WT1 as a Universal Marker for Minimal Residual Disease Detection and Quantification in Myeloid Leukemias and in Myelodysplastic Syndrome in another window